65 / 84
65
Fluprednisolone OR Flurandrenolone OR Flurogestone OR
Paramethasone OR Triamcinolone OR Prednisolone OR
Hydrocortisone OR corticosteroids OR Mineralocorticoids OR
Glucocorticoids
OR
Hydroxycorticosteroids)
AND
((clinical[Title/Abstract] AND trial[Title/Abstract]) OR
clinical trials[MeSH Terms] OR clinical trial[Publication Type]
OR random*[Title/Abstract] OR random allocation[MeSH
Terms] OR therapeutic use[MeSH Subheading])
QUESTÃO 6: Em que situações o uso contínuo de
AINH deve ser recomendado em pacientes com
EA?
(Spondylitis, Ankylosing OR Bechterew's Disease OR
Ankylosing Spondyloarthritis OR Rheumatoid Spondylitis OR
Marie-Struempell Disease) AND (Anti-Inflammatory Agents
OR Cyclooxygenase 2 OR COX-2 OR rofecoxib OR Ibuprofen
OR celecoxib OR Naproxen OR Acetaminophen OR NSAID
OR paracetamol OR parecoxib OR diclofenac OR aspirin OR
meloxicam OR acetylsalicylic OR piroxicam) AND
(randomized
controlled
trial[Publication
Type]
OR
(randomized[Title/Abstract] AND controlled[Title/Abstract]
AND trial[Title/Abstract]))
QUESTÃO 7: Quais são as evidências para o uso
de drogas de base convencionais (metotrexato e
sulfasalazina, entre outras) em pacientes com EA?
Spondylitis, Ankylosing OR Bechterew's Disease OR
Ankylosing Spondyloarthritis OR Rheumatoid Spondylitis OR